Ceres (CERE) Reports Q3 Loss Per Share of $0.98
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ceres Announces Fiscal Third Quarter 2015 Financial Results
July 10, 2015 4:05 PM EDTTHOUSAND OAKS, Calif., July 10, 2015 /PRNewswire/ --Â Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, announced today financial results for the three months ended May 31, 2015 and provided an update on its business and product development pipeline.
The company reported that it has signed a collaboration and license agreement with a leading agricultural producer to introduce Ceres' biotech traits following positive results from greenhouse and field evaluations. Separately, the company announced that it has substantially increased... More
